Fig. 2From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugsThe results of the mode of action assays from the entry stage. A The percentage of HCV infection in the virucidal activity assay of the FR3T3 sub-fraction, B the percentage of HCV infection in the host cell expression activity assay, C Number of copies of RNA from the VHC absorption test on FR3T3 sub-fraction treated Huh7it-1 cellsBack to article page